Intrinsiqs

Is Scribe Therapeutics Inc. overvalued?

Scribe Therapeutics Inc. (SCTX) — key valuation metrics and fundamentals.

No verdict
Price
$19.50
Fair value
Current P/E
Normal P/E
Market cap
$304.1M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares SCTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jul 2026.